Response to hepatitis B vaccine: Multiple HLA genes are involved

Tissue Antigens

Volumn 51, Issue 6, 1998, Pages 593-604

  Desombere, I ^a   Willems, A ^a   Leroux Roels, G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Hepatitis B surface antigen; Hepatitis B vaccines; HLA antigens; Immune response; Nonresponse

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR7 ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; GENE LINKAGE DISEQUILIBRIUM; GENETIC REGULATION; HAPLOTYPE; HEPATITIS B; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VACCINATION;

EID: 0031801983     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03001.x     Document Type: Article

References (33)

1. Grob PJ, Jilg W, Milne A, Townsend TR. Unresolved issues in hepatitis B immunization. In: Hollinger FB, Lemon SM, Margolis HS, ed. Viral hepatitis and liver disease: Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991: 856-60.
2. Katkov WN, Dienstag JL. Prevention and therapy of viral hepatitis. Semin Liver Dis 1991: 11: 165-74.
3. Walker M, Szmuness W, Stevens CE, Rubinstein P. Genetics of anti-HBs responsiveness. I. HLA DR7 and nonresponsiveness to hepatitis vaccination. Transfusion 1981: 21: 601.
4. Usonis V, Kühnl P, Brede HD, Doerr HW. Humoral immune response after hepatitis B vaccination: kinetics of anti-HBs antibodies and demonstration of HLA antigens. Zentralbl Bakteriol Mikrobiol Hyg A 1986: 262: 377-84.
5. Craven DE, Awdeh ZL, Kunches LM et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med 1986: 105: 356-60.
6. Varla-Leftherioti M, Papanicolaou M, Spyropoulou M et al. HLA-associated nonresponsiveness to hepatitis B vaccine. Tissue Antigens 1990: 35: 60-3.
7. Weissman JY, Tsuchiyose MM, Tong MJ, Co R, Chin K, Ettenger RB. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine. JAMA 1988: 260: 1734-8.
8. Dondi E, Finco O, Mantovani V, Mele L, Ruberto G, Cuccia M. Involvement of HLA and C4 in the non responsiveness to hepatitis B vaccine. Fundam Clin Immunol 1996: 4: 73-8.
9. Alper CA, Kruskall MS, Marcus-Bagley D et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989: 321: 708-12.
10. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992: 175: 495-502.
11. + suppressor T cells. Hum Immunol 1988: 22: 9-17.
12. Watanabe H, Okumura M, Hirayama K, Sasazuki T. HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis B surface antigen via CD8-positive suppressor T cells. Tissue Antigens 1990: 36: 69-74.
13. Hatae K, Kimura A, Okubo R et al. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype. Eur J Immunol 1992: 22: 1899-905.
14. McDermott AB, Zuckerman JN, Sabin CA, Marsh SGE, Madrigal JA. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997: 50: 8-14.
15. Leroux-Roels G, Desombere I, De Tollenaere G et al. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults. Vaccine 1997: 15: 1724-31.
16. Leroux-Roels G, Desombere I, Cobbaut L et al. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines. Vaccine 1997: 15: 1732-6.
17. Takahashi H, Liang JT, Blum HE et al. Identification of low-level hepatitis B viral genome in hepatitis B vaccine nonresponders in Japan. In: Hollinger FB, Lemon SM, Margolis H, ed. Viral hepatitis and liver disease: Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkins, 1991: 779-81.
18. Luo K-X, Wang L-P, Nie J, Jiang S. Is nonresponsiveness to hepatitis B vaccines due to latent hepatitis B virus infection? J Infect Dis 1992: 165: 777-8.
19. Leroux-Roels G, Van Hecke E, Michielsen W, Voet P, Hauser P, Pêtre J. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines. Vaccine 1994: 12: 812-8.
20. Buyse I, Decorte R, Baens M et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993: 41: 1-14.
21. Hollinger FB, Adam E, Heiberg D, Melnick LJ. Responses to hepatitis B vaccine in a young adult population. In: Szmuness W, Alter HJ, Maynard JE, ed. Viral Hepatitis: 1981. International Symposium. Philadelphia: Franklin Institute Press, 1982: 451 66.
22. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955: 19: 251-3.
23. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994: 43: 18 27.
24. De Koster HS, Kenter MJH, D'Amaro J et al. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules. Immunogenetics 1991: 34: 12-22.
25. Termijtelen A, Naipal van den Berge S, Suwam di-Thung L, van Rood JJ. Recognition of DP determinants with typing reagents prepared with lymphocytes from Dutch unrelated individuals. Tissue Antigens 1985: 26: 234-42.
26. Buyse I, Sandkuyl LA, Ghabanbasani MZ et al. Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population. Diabetologia 1994: 37: 808-17.
27. Milich DR, Chisari FV. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol 1982: 129:320-5.
28. Milich DK, Leroux-Roels GG, Louie RE, Chisari FV. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C sub-regions. J Exp Med 1984: 159: 41 56.
29. Bignon JD, Cheneau ML, Herry P, Bonneville F, Cesbron A, Muller JY. Strong linkage disequilibrium of HLA DPw11 with the HLA B44-DR7-DQw2 extended haplotype. Tissue Antigens 1992: 39: 35-7.
30. Martinetti M, Cuccia M, Daielli C et al. Anti-HBV neonatal immunization with recombinant vaccine. Part II. Molecular basis of the impaired alloreactivity. Vaccine 1995: 13: 555-60.
31. Desombere I, Hauser P, Rossau R, Paradijs J, Leroux-Roels G. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. J Immunol 1995: 154: 520-9.
32. Salazar M, Deulofeut H, Granja C et al. Normal HBsAg presentation and T-cell defect in the immune response of nonresponders. Immunogenetics 1995: 41: 366-74.
33. Wilson AG, de Vries N, Pociot F, de Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumour necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993: 177: 557-60.